Claritev is showing early signs of a turnaround, with revenue and bookings growth supporting a Buy r

The WTC Health Program is a limited federal health care program established under the James Zadroga

Barclays analyst Glen Santangelo maintains Claritev (NYSE:CTEV) with a Overweight and raises the

Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company, today announ

Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and raise

CTEV reported better-than-expected Q2 results and raised FY26 sales guidance. Analysts maintain Buy

Citigroup analyst Daniel Grosslight maintains Claritev (NYSE:CTEV) with a Buy and raises the pric

Canaccord Genuity analyst Richard Close maintains Claritev (NYSE:CTEV) with a Buy and raises the

Claritev (NYSE:CTEV) raises FY2026 sales outlook from $985.000 million-$1.000 billion to $1.000 bill

Claritev (NYSE:CTEV) reported quarterly losses of $(3.49) per share which beat the analyst consensus

Canaccord Genuity analyst Richard Close maintains Claritev (NYSE:CTEV) with a Buy and raises the

As stated in the Form 8-K filed on May 18, 2026, in August 2024 Claritev Corporation (the "Compa

Canaccord Genuity analyst Richard Close initiates coverage on Claritev (NYSE:CTEV) with a Buy rat

Smart credit team Ares Mgmt bought discounted BDCs aggressively in Q1 2026. They're not guessing

An article published on Thursday, May 14, 2026 alleges that "DOJ launches criminal antitrust pro

Claritev (NYSE:CTEV) raises FY2026 sales outlook from $980.000 million-$1.000 billion to $985.000 mi

Claritev (NYSE:CTEV) reported quarterly losses of $(4.41) per share which missed the analyst consens

Barclays analyst Glen Santangelo initiates coverage on Claritev (NYSE:CTEV) with a Overweight rat

Wells Fargo analyst Stan Berenshteyn maintains Claritev (NYSE:CTEV) with a Equal-Weight and lower